$Entero Therapeutics(ENTO)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001104659-25-113171 Act: 34 Size: 21 KB 网页链接
Entero Therapeutics(ENTO)
2025-11-14 03:35
$Entero Therapeutics(ENTO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001037389-25-000069 Act: 34 Size: 9 KB 网页链接
Entero Therapeutics(ENTO)
2025-11-07 05:05
$Entero Therapeutics(ENTO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-25-107715 Act: 34 Size: 191 KB 网页链接
$Entero Therapeutics(ENTO)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001104659-25-089562 Act: 34 Size: 237 KB 网页链接
Entero Therapeutics(ENTO)
2025-09-11 05:25
$Entero Therapeutics(ENTO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-25-089120 Act: 33 Size: 558 KB 网页链接
Entero Therapeutics(ENTO)
2025-09-10 05:05
$Entero Therapeutics(ENTO)$ 8-K Current report, items 1.02, 5.02, and 9.01 Accession Number: 0001104659-25-088663 Act: 34 Size: 197 KB 网页链接
Entero Therapeutics(ENTO)
2025-08-27 04:35
$Entero Therapeutics(ENTO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-25-083105 Act: 33 Size: 725 KB 网页链接
Entero Therapeutics(ENTO)
2025-08-27 04:15
$Entero Therapeutics(ENTO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-25-083075 Act: 34 Size: 2 MB 网页链接
Entero Therapeutics(ENTO)
2025-08-19 07:05
$Entero Therapeutics(ENTO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-25-079924 Size: 3 KB 网页链接
Entero Therapeutics(ENTO)
2025-08-19 07:05
$Entero Therapeutics(ENTO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-25-079923 Size: 3 KB 网页链接
Entero Therapeutics(ENTO)
2025-08-18 22:45
$Entero Therapeutics(ENTO)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001104659-25-079619 Act: 33 Size: 11 KB 网页链接